DLA Piper represented lululemon athletica inc., a company that creates yoga-inspired athletic apparel, in connection with a transaction through which Advent International, a global private equity firm, acquired a 14 percent stake in lululemon from Chip Wilson, the company’s founder, for US$845 million. More >>
Tags: DLA Piper | New York | Seattle
Goodwin Procter attorneys recently advised Gallus BioPharmaceuticals in its sale to DPx Holdings, parent company of Patheon, DSM Fine Chemicals and Banner Life Sciences. Goodwin also advised financial sponsor Ridgemont Equity Partners of Charlotte, N.C. and the senior management team of Gallus in the transaction. The transaction closed on September 29, 2014. More >>
Tags: Goodwin Procter LLP | Boston | WashingtonSimpson Thacher is representing Hilton Worldwide Holdings Inc. (“Hilton Worldwide”) in its announced agreement with Anbang Insurance Group Co. Ltd. (“Anbang”) to sell the Waldorf Astoria New York for $1.95 billion. Hilton Worldwide will be granted a management agreement by Anbang to continue to operate the property for the next 100 years. More >>
Tags: New York
A Weil team advised Goldman Sachs in providing $9.1 billion of fully committed bridge financing to Becton Dickinson & Co., a leading medical technology company, to finance its $12.2 billion acquisition of CareFusion Corp., a global healthcare company that provides products and services to hospitals. The transaction, which is expected to close in the first half of 2015, will create a global leader in medication management and patient safety solutions. More >>
Tags: Weil, Gotshal & Manges, LLP | New York | Washington
Global law firm White & Case LLP has advised the Abu Dhabi Water and Electricity Authority (ADWEA) on the successful financial close of the US$1.2 billion Mirfa Independent Water and Power Project.
“This transaction represents the tenth independent water/power project that White & Case has advised on for ADWEA, which began its power sector privatization in 1997,” said White & Case partner Michael Watson. “This is another important project for Abu Dhabi and demonstrates the continued success of the ADWEA privatization model.” More >>
Tags: White & Case LLP | Abu Dhabi
Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and other growth enterprises worldwide, is pleased to announce that the firm has opened a new office in Wilmington, Delaware. The Wilmington office will focus on key Delaware practices, including corporate law, corporate governance counseling, special committees, internal investigations, and litigation relating to mergers and acquisitions, governance, and securities matters. More >>
Tags: Wilson Sonsini Goodrich & Rosati | Wilmington
Cahill represented Merrill Lynch, Pierce, Fenner & Smith Incorporated as lead underwriter and the other underwriters in connection with the Initial Public Offering of 25,532,000 common shares of VWR Corporation (NASDAQ: VWR), a leading independent provider of laboratory products, services and solutions to the global life science, general research and applied markets, resulting in gross proceeds of $536,172,000. Proceeds were used to refinance existing indebtedness and for general corporate purposes.
Tags: Cahill Gordon & Reindel LLP | New York
Clifford Chance has advised its longstanding client O1 Group on the acquisition and on the acquisition financing of a 16% stake in Austrian CA Immo from UniCredit. The total value of the transaction is EUR295 million.
The 15,954,891 ordinary shares acquired by O1 Group Limited represent the entire participation currently held by UniCredit in CA Immo and correspond to approximately 16.35% of the outstanding share capital and voting rights of CA Immo. The closing of the acquisition by O1 Group Limited of UniCredit’s shares in CA Immo is subject to the fulfilment of customary conditions precedent, such as merger control clearance, and expected to occur in November 2014. More >>
Tags: Clifford Chance LLP | Düsseldorf | Moscow
Alios BioPharma, Inc., a biotechnology company developing proprietary therapeutics for viral diseases, announced on September 30, 2014 a definitive agreement with Johnson & Johnson whereby Alios will be acquired for approximately $1.75 billion in cash payable upon closing of the transaction. The transaction has been approved by the boards of directors of both companies. More >>
Tags: Knobbe Martens | San Diego